GlaxoSmithKline reported GBP60.15B in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alcon AG ALC:SW USD 29.21B 1.41B
Amgen AMGN:US USD 65.12B 1.42B
Artemis Alpha ATS:LN GBP 129.48M 35.04M
AstraZeneca AZN:LN USD 96.48B 2.3B
Bayer BAYN:GR EUR 124.88B 6.13B
Biogen BIIB:US USD 24.55B 300.1M
Fresenius FRE:GR EUR 76.42B 3.91B
Fresenius Medical Care FME:GR EUR 35.75B 2.65B
Galapagos GLPG:NA EUR 4.73B 237.72M
Genmab GEN:DC DKK 30.28B 408M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Glaxosmithkline GSK:US GBP 60.15B 167M
Hikma Pharmaceutical HIK:LN USD 4.47B 276M
Lonza Group LONN:SW CHF 17.36B 613M
Merck MRK:GR EUR 48.53B 2.41B
Novartis NOVN:VX USD 117.45B 1.01B
Orion ORNBV:FH EUR 1.5B 63.9M
Recordati REC:IM EUR 3.98B 6.24M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Roche Holding ROG:VX 88.15B 1.42B
Smith & Nephew PLC SN/:LN 10.1B 815M